AGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy ...

The cell and gene therapy space in recent months has hit several speedbumps, including layoffs, dropped drugs and ...

These circular DNA molecules are used both as raw materials in viral vector production and as active pharmaceutical ingredients in some therapeutic modalities. One of the primary drivers of this ...

Hovione and Firstgene Life Sciences have entered a strategic collaboration to advance Hovione’s virus-like particle drug ...

New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal ...

CDMO Andelyn Biosciences says that it has manufactured a viral vector with its AAV Curator ® Platform for the Nationwide Children’s Hospital’s Cellular Therapy and Cancer Immunology Program.

Thermo Fisher did not immediately respond to Pharmaceutical Technology on whether existing ... The company continued its strategic withdrawal from the viral vector manufacturing space in February, ...

"The data we will present at ASGCT underscore the power and versatility of Encoded's vector engineering platform to target a wide array of validated disease pathways with potential one-time treatments ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) announced today that it will present updated preclinical data from its proprietary J-Brain Cargo ® -applied adeno-associated virus (AAV) vector gene ...

Japan Tobacco Inc. ( OTCPK:JAPAY) Q1 2025 Results Conference Call May 7, 2025 6:00 AM ET Hiromasa Furukawa - Group Chief Financial Officer Dinesh Babu Thotakura - General Manager Nobuya Kato - JTI ...